We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cryopreserved Erythrocytes Processed for Blood Transfusion

By LabMedica International staff writers
Posted on 10 Apr 2012
Print article
Cryostorage of red blood cells (RBCs) represents a valid alternative to liquid storage, since units can be preserved safely for at least a decade while conserving cell viability.

Preservation of blood for transfusion purposes has represented a lifesaving advance in clinical practice over many years, but although cryostorage has attracted a great deal of attention clinically, little is known about the biochemistry and physiology of cryostored erythrocyte concentrates.

Specialists at the University of Tuscia (Viterbo, Italy) investigated cryostorage of RBCs through monitoring of cell processing steps, from fresh blood, to glycerolization, thawing, and deglycerolization, followed by washing. Whole blood was collected from 10 healthy donor volunteers into 63 mL of citrate phosphate dextrose (CPD) anticoagulant, and leukodepleted. All glycerolized RBC units were frozen and stored at −80 ± 10 °C in a mechanical freezer for at least 12 months.

The erythrocytes were monitored through repeated assays of standard parameters of mean cell volume (MCV), red cell distribution width-standard deviation (RDW-SD), the mean cell hemoglobin concentration (MCHC), and the hematocrit (Hct). These were determined with a CA 530-Oden hematology analyzer. Scanning electron microscopy was also performed. Other standard biological indicators, such as hemoglobin content, pH values both internal and in the supernatant, lactate levels, osmotic fragility and hemolysis, were also calculated.

Cell processing for cryostorage resulted in increased RBC volumes. Mean cell volume (MCV) increased significantly upon glycerolization, from 89.4 ± 4.5 fL of fresh RBCs to 126.04 ± 2.3 fL of glycerolized RBCs, while it remained constant at 129.6 ± 3.3 fL upon cryostorage even after thawing. Deglycerolization and washing restored lower MCV values 93.7 ± 5.9 fL, though they were still higher than controls. Shape alterations caused an increase in osmotic fragility and permeability to ions. A significant pH drop was observed which could not to be attributed to a higher metabolic rate, since the levels of lactate did not show substantial fluctuation during the cell processing steps tested in this study. The membrane anomalies reported are likely related to the hemolysis observed which preferentially affected the densest and oldest cell sub-populations, as confirmed by means of discontinuous density gradients. The CA 530-Oden hematology analyzer used in the study is manufactured by Medonic (Stockholm, Sweden).

The authors concluded that their results indicate that cryostorage itself in presence of glycerol does not significantly affect RBCs. Most of the alterations observed were related to cell processing and, in particular, to the increase of cytosolic glycerol as a consequence of the glycerolization step. Further studies might profitably investigate replacing glycerol with nonpenetrating cryoprotectants such as polyvinylpyrrolidone or polyethylene glycol, or the less toxic sucrose and trehalose.The study was published online on March 14, 2012, in the journal Blood Cells, Molecules, and Diseases.

Related Links:

University of Tuscia
Medonic


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
TETANUS Test
TETANUS VIRCLIA IgG MONOTEST

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.